» Articles » PMID: 30713742

Crystal Structure and Hirshfeld Surface Analysis of 3,4-dihydro-2-(2,4-dioxo-6-methylpyran-3-ylidene)-4-(4-pyridin-4-yl)-1,5-benzodiazepine

Overview
Date 2019 Feb 5
PMID 30713742
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The title compound, CHNO [systematic name: 2-(6-methyl-2,4-dioxo-pyran-3-yl-idene)-4-(pyridin-4-yl)-2,3,4,5-tetra-hydro-1-1,5-benzodiazepine], is built up from a benzodiazepine ring system linked to pyridyl and pendant di-hydro-pyran rings, where the benzene and pyridyl rings are oriented at a dihedral angle of 43.36 (6)°. The pendant di-hydro-pyran ring is rotationally disordered in a 90.899 (3):0.101 (3) ratio with the orientation of each component largely determined by intra-molecular N-H⋯O (Diazp = diazepine and Dhydp = di-hydro-pyran) hydrogen bonds. In the crystal, mol-ecules are linked via pairs of weak inter-molecular N-H⋯O hydrogen bonds, forming inversion-related dimers with (26) ring motifs. The dimers are further connected along the -axis direction by π-π stacking inter-actions between the pendant di-hydro-pyran and pyridyl rings with centroid-centroid distances of 3.833 (3) Å and a dihedral angle of 14.51 (2)°. Hirshfeld surface analysis of the crystal structure indicates that the most important contributions for the crystal packing are from H⋯H (50.1%), H⋯C/C⋯H (17.7%), H⋯O/O⋯H (16.8%), C⋯C (7.7%) and H⋯N/N⋯H (5.3%) inter-actions. Hydrogen-bonding and van der Waals inter-actions are the dominant inter-actions in the crystal packing.

Citing Articles

Crystal structure, Hirshfeld surface analysis and inter-action energy calculation of 4-(furan-2-yl)-2-(6-methyl-2,4-dioxo-pyran-3-yl-idene)-2,3,4,5-tetra-hydro-1-1,5-benzodiazepine.

El Hafi M, Lahmidi S, El Ghayati L, Hokelek T, Mague J, Amer B Acta Crystallogr E Crystallogr Commun. 2021; 77(Pt 8):834-838.

PMID: 34422311 PMC: 8340973. DOI: 10.1107/S2056989021007441.


Synthesis, crystal structure and Hirshfeld surface analysis of 3-(4,4-dimethyl-2,3,4,5-tetra-hydro-1-1,5-benzodiazepin-2-yl-idene)-6-methyl-3,4-di-hydro-2-pyran-2,4-dione.

Samba M, Minnih M, Hokelek T, Kaur M, Jasinski J, Sebbar N Acta Crystallogr E Crystallogr Commun. 2019; 75(Pt 2):228-232.

PMID: 30800456 PMC: 6362647. DOI: 10.1107/S2056989019000689.

References
1.
Hathwar V, Sist M, Jorgensen M, Mamakhel A, Wang X, Hoffmann C . Quantitative analysis of intermolecular interactions in orthorhombic rubrene. IUCrJ. 2015; 2(Pt 5):563-74. PMC: 4547824. DOI: 10.1107/S2052252515012130. View

2.
Jabli H, Rodi Y, Saffon N, Essassi E, Ng S . 3-Allyl-1,5-dibenzyl-1,5-benzodiazepine-2,4-dione. Acta Crystallogr Sect E Struct Rep Online. 2011; 65(Pt 12):o3150. PMC: 2972173. DOI: 10.1107/S160053680904851X. View

3.
McKinnon J, Jayatilaka D, Spackman M . Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces. Chem Commun (Camb). 2008; (37):3814-6. DOI: 10.1039/b704980c. View

4.
Dardouri R, Chahdi F, Saffon N, Essassi E, Ng S . 1,3-Dimethyl-3-tetra-decyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione. Acta Crystallogr Sect E Struct Rep Online. 2011; 67(Pt 3):o674. PMC: 3052003. DOI: 10.1107/S1600536811005782. View

5.
De Sarro G, Gitto R, Rizzo M, Zappia M, DE Sarro A . 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice. Gen Pharmacol. 1996; 27(6):935-41. DOI: 10.1016/0306-3623(95)02147-7. View